Unlocking Practical Impact: Lessons from AI-Driven TB Detection in India

The integration of artificial intelligence in tuberculosis (TB) detection, exemplified by DeepTek’s Genki platform, marks a significant leap in India’s public health response. As the country grapples with the world’s highest TB burden, deploying AI-powered diagnostic tools is not just a technological upgrade—it is a strategic intervention shaped by the realities of accessibility, cost, and health system capacity. The implementation journey of Genki offers critical insights into how digital health innovations can be effectively scaled in diverse, resource-constrained environments, while aligning with national priorities and global standards.

Bridging Diagnostic Gaps: Rapid AI Deployment in Rural India

A central challenge in India’s TB control efforts is the slow, resource-intensive nature of traditional diagnostics, particularly in rural and underserved regions. Genki’s AI-powered analysis of chest X-rays—delivering results within 30 to 60 seconds—directly addresses this bottleneck. By equipping mobile radiology units and health camps with Genki, states like Maharashtra and Tamil Nadu have extended rapid TB screening to remote tribal communities, where access to radiologists and diagnostic labs is limited. This approach dovetails with the National Tuberculosis Elimination Programme (NTEP), which prioritizes early detection and treatment adherence. The reduction in diagnostic delays not only accelerates treatment initiation but also curtails disease transmission, demonstrating how AI can bridge persistent healthcare gaps.

Policy Alignment and Public-Private Partnerships: Catalysts for Scale

The successful rollout of Genki underscores the importance of institutional collaboration and policy support. DeepTek’s partnerships with state governments in Tamil Nadu and Maharashtra have enabled pilot projects that serve as blueprints for broader adoption. These pilots, supported by the Atmanirbhar Bharat initiative’s emphasis on indigenous innovation, provide critical operational data—ranging from user acceptance to logistical challenges—that inform iterative improvements. Regulatory milestones, such as Genki’s CE certification under the EU Medical Device Regulation (Class IIb), further enhance credibility and pave the way for international deployment.

Infrastructure and Capacity: Overcoming Implementation Barriers

Despite promising results, scaling AI diagnostics like Genki requires addressing persistent infrastructure and human resource challenges. Reliable electricity, robust digital connectivity, and secure data management are prerequisites for effective deployment, especially in mobile settings. The Digital India and BharatNet initiatives aim to strengthen rural connectivity, facilitating the operation of AI-enabled units. Equally crucial is the training of frontline health workers—often the first point of contact in rural areas—to operate AI tools and interpret results. Pilot programs have shown that with targeted training, even non-specialist health workers can effectively use Genki, expanding the reach of quality diagnostics. Data privacy and security, governed by the Digital Personal Data Protection (DPDP) Act, 2023, remain central to maintaining patient trust and regulatory compliance.

Learning from Global and Local Experiences

India’s AI-driven TB detection efforts resonate with global trends, yet are tailored to local realities. South Africa’s integration of AI chest X-ray analysis in national TB programs, for example, highlights the value of compensating for radiologist shortages and expediting diagnosis in high-burden settings. However, India’s approach—characterized by decentralized pilots and public-private partnerships—offers a more agile model compared to the centralized health data systems seen in South Africa or the heavily regulated landscape of the United States. Continuous monitoring, robust training, and community engagement are vital to ensuring accuracy, equity, and sustained impact.

Expert Perspectives: Indian Voices on Responsible AI Adoption

Indian experts emphasize both the promise and the complexities of AI in healthcare implementation. Dr. Amit Kharat, co-founder of DeepTek, notes that AI tools like Genki “democratize access to quality diagnostics by augmenting, not replacing, human expertise—especially in resource-limited settings.” Dr. Soumya Swaminathan, former Chief Scientist at WHO and a leading Indian TB expert, stresses the need for “rigorous validation and integration of AI diagnostics within national TB programs to ensure alignment with treatment protocols and data systems.”

—

The implementation of AI-driven TB detection in India illustrates the interplay between technological innovation, policy facilitation, and ground-level realities. By learning from pilot deployments, investing in infrastructure and workforce capacity, and fostering multi-sector partnerships, India is setting a precedent for responsible, scalable digital health solutions that can be adapted both nationally and globally.

AI-Driven TB Detection: India in the Global Arena

Artificial intelligence is rapidly reshaping the landscape of infectious disease diagnostics worldwide. India’s deployment of AI-powered tools like Genki for tuberculosis (TB) detection exemplifies a broader international movement, where countries tailor AI solutions to their unique healthcare challenges. By examining global models—from South Africa’s public health integration to China’s data-driven surveillance and the United States’ regulatory rigor—India’s approach emerges as both innovative and adaptive. These comparative perspectives offer valuable lessons for policy, implementation, and the future of AI in healthcare.

Integrating AI into National TB Programs: Lessons from South Africa and India

South Africa, grappling with one of the world’s highest TB burdens, has pioneered the integration of AI-based chest X-ray screening within its national TB programs. Faced with a critical shortage of radiologists, the South African government adopted AI tools to accelerate diagnosis, particularly in high-prevalence and underserved regions. Mobile screening units equipped with AI technology have become a cornerstone of their outreach, echoing India’s own mobile TB camps powered by Genki. However, South Africa’s progress is bolstered by a robust, centralized health data infrastructure, enabling seamless data sharing and rapid scale-up of AI interventions—a domain where India is making significant strides through the National Health Stack and the National Digital Health Mission.

China’s Data-Driven Model: AI, Big Data, and Outbreak Prediction

China’s approach to AI in TB detection is characterized by large-scale government investment and deep integration with electronic health records (EHRs). By combining AI with big data analytics, China not only enhances diagnostic accuracy but also enables real-time outbreak prediction and resource optimization. For instance, AI-powered surveillance systems in cities like Shanghai monitor TB trends and trigger rapid public health responses. This model’s strength lies in its centralized data governance and extensive funding, contrasting with India’s more decentralized, pilot-driven innovation ecosystem. India’s Atmanirbhar Bharat initiative, however, reflects a growing commitment to indigenous AI development, with Genki’s CE certification aligning Indian products with international standards and opening doors for global collaboration.

Regulatory Frameworks: Balancing Innovation with Oversight

The United States presents a different paradigm, where AI tools for TB detection are primarily confined to research and specialized clinical settings. The U.S. Food and Drug Administration (FDA) enforces stringent approval processes to ensure safety and efficacy, which, while safeguarding patients, can slow the pace of AI deployment. In contrast, India’s regulatory environment is evolving rapidly. The introduction of regulatory sandboxes and ethical guidelines under the Ministry of Electronics and Information Technology (MeitY) allows for agile experimentation while maintaining oversight. The recent CE certification of Genki signals India’s intent to harmonize with global standards, enhancing both domestic trust and international marketability. The Digital Personal Data Protection (DPDP) Act, 2023, further strengthens India’s commitment to data privacy—a critical consideration for AI in healthcare.

Indian Expert Perspectives: Navigating Opportunities and Challenges

Indian experts and institutions are at the forefront of shaping the country’s AI trajectory in healthcare. Dr. Amit Kharat, co-founder of DeepTek, notes that “AI tools like Genki democratize access to quality diagnostics, particularly in resource-constrained settings, by augmenting—not replacing—human expertise.” Dr. Soumya Swaminathan, former Chief Scientist at WHO, emphasizes the necessity of integrating AI diagnostics within national TB programs to ensure consistency with treatment protocols and data reporting. She advocates for “rigorous validation and ongoing monitoring to safeguard diagnostic equity and accuracy.” Research bodies such as the Indian Council of Medical Research (ICMR) and AIIMS are actively exploring ethical frameworks and data privacy standards, while the Centre for Artificial Intelligence and Robotics (CAIR) under DRDO contributes to policy discussions on AI governance and security.

Toward a Global Model: Policy Alignment and Cross-Border Collaboration

India’s evolving AI policy ecosystem reflects a synthesis of global best practices and local innovation. Initiatives like the IndiaAI Mission and the National Tuberculosis Elimination Programme (NTEP) integrate AI into public health strategy, while regulatory sandboxes and ethical guidelines foster responsible experimentation. India’s emphasis on indigenous innovation under Atmanirbhar Bharat distinguishes its approach from China’s state-driven model and the U.S.’s market-driven system. The CE certification of Genki not only validates its technical rigor but also enhances its export potential, facilitating cross-border partnerships and knowledge exchange. As India refines its regulatory frameworks and invests in digital infrastructure, it is well-positioned to contribute to—and learn from—the global community in advancing AI-driven healthcare solutions.

—

India’s journey in AI-driven TB detection is emblematic of a broader global shift toward intelligent, equitable, and scalable healthcare solutions. By learning from international models and leveraging its own strengths in innovation and policy, India is poised to set new benchmarks in the fight against tuberculosis and beyond.

AI’s Expanding Role: Transforming Health and Public Services in India

Artificial intelligence is rapidly reshaping India’s healthcare and public service landscape, moving far beyond its initial applications in tuberculosis (TB) detection. From revolutionizing disease screening to optimizing agricultural outputs and strengthening digital infrastructure, AI-driven solutions are addressing some of the country’s most pressing challenges. This section explores the breadth of AI’s impact, drawing on real-world examples, policy initiatives, and expert insights to illustrate how India is leveraging AI for societal benefit.

AI-Enabled Diagnostics: From Eye Care to Oncology

AI-powered diagnostic tools are increasingly central to India’s healthcare innovation. Notably, the Aravind Eye Care System employs deep learning algorithms to screen for diabetic retinopathy among rural populations, a critical intervention that has significantly reduced preventable blindness. According to a 2021 NITI Aayog report, Aravind’s AI system has screened over 70,000 patients in Tamil Nadu, enabling early detection and timely treatment.

Startups such as Qure.ai and SigTuple are deploying AI models to analyze radiology images and pathology slides for early cancer detection. Qure.ai’s chest X-ray interpretation tool, for instance, is used in both public and private hospitals to flag potential lung cancer and TB cases, improving diagnostic accuracy and reducing turnaround times. Meanwhile, Niramai’s AI-based thermal imaging platform offers non-invasive breast cancer screening, particularly benefiting women in underserved rural areas by providing radiation-free diagnostics.

These innovations are supported by government initiatives like the IndiaAI Mission, which fosters collaboration between academia, industry, and public health agencies to accelerate the integration of AI in healthcare.

Digital Health Infrastructure: Building the Foundation for Scalable AI

India’s ambitious digital health infrastructure projects are laying the groundwork for widespread AI adoption. The National Health Stack, envisioned by NITI Aayog, aims to create a unified digital ecosystem that integrates electronic health records, insurance claims, and AI-powered analytics. This infrastructure enables scalable deployment of AI diagnostics and supports data-driven public health interventions.

The National Digital Health Mission (NDHM) further advances this vision by promoting interoperable health data systems and encouraging the integration of AI tools for disease surveillance and personalized care. Pilot projects in states like Andhra Pradesh and Kerala have demonstrated the feasibility of linking AI-powered screening tools with digital health records, streamlining patient management and resource allocation.

The Ministry of Health and Family Welfare’s guidelines on digital health emphasize the importance of data privacy, interoperability, and ethical AI deployment, reflecting India’s commitment to responsible innovation.

AI in Agriculture: Indirect Health and Social Benefits

Beyond healthcare, AI applications in agriculture are contributing to improved public health outcomes by enhancing food security and rural livelihoods. Indian agri-tech startups such as CropIn and AgNext use AI for crop disease detection, yield prediction, and supply chain optimization. For example, CropIn’s SmartFarm platform leverages satellite imagery and machine learning to alert farmers about pest outbreaks, enabling timely intervention and reducing crop losses.

These advances indirectly impact health by ensuring stable food supplies and increasing farmers’ incomes, which are critical determinants of nutrition and well-being. Government programs like the Pradhan Mantri Fasal Bima Yojana (PMFBY) are exploring AI-driven risk assessment models to streamline crop insurance and disaster response, further strengthening rural resilience.

Research and Policy Leadership: Indian Institutions at the Forefront

India’s leading academic and research institutions are at the vanguard of AI innovation. The Indian Institute of Technology (IIT) network and the All India Institute of Medical Sciences (AIIMS) are actively researching AI applications in infectious disease modeling, personalized medicine, and health system optimization. For instance, IIT Delhi’s Centre for Biomedical Engineering has developed AI models for predicting dengue outbreaks, aiding public health planning.

Policy think tanks such as NITI Aayog and the Ministry of Electronics and Information Technology (MeitY) provide strategic direction for AI adoption. The IndiaAI Mission and the Digital Personal Data Protection (DPDP) Act, 2023, establish frameworks for ethical AI use and data privacy, ensuring that technological advancements align with societal values and legal safeguards.

Expert Perspectives: Navigating Opportunities and Challenges

Indian experts underscore both the promise and the complexities of AI integration. Dr. Amit Kharat, co-founder of DeepTek, notes that “AI democratizes access to quality diagnostics, especially in resource-limited settings, by augmenting—not replacing—human expertise.” Dr. Soumya Swaminathan, former Chief Scientist at WHO, emphasizes the need for rigorous validation and integration of AI tools within national health programs to ensure consistency and equity.

Institutions like the Indian Council of Medical Research (ICMR) and the Centre for Artificial Intelligence and Robotics (CAIR) are developing ethical frameworks and data governance protocols to address concerns around bias, privacy, and accountability. These efforts align with India’s broader push for transparent and inclusive AI governance, as outlined in MeitY’s 2025 strategy.

—

India’s strategic embrace of AI across healthcare and public services demonstrates a commitment to leveraging technology for social good. By fostering innovation, strengthening digital infrastructure, and prioritizing ethical deployment, India is setting a benchmark for responsible and impactful AI adoption in the Global South.

Transforming TB Care: Real Stories from the Frontlines of AI Innovation

The integration of AI-powered tools like Genki into India’s tuberculosis (TB) response is reshaping the landscape of public health, especially in underserved regions. From tribal Maharashtra to remote Tamil Nadu, Genki’s deployment has enabled rapid, accurate TB diagnosis, bridging gaps in healthcare access and empowering frontline workers. These impact stories illuminate not only the clinical benefits but also the broader social, economic, and policy implications of AI-driven diagnostics in India’s fight against TB.

Accelerating Early Detection in Rural Maharashtra

In the tribal districts of Maharashtra, where healthcare infrastructure is sparse, mobile screening camps equipped with Genki have revolutionized TB detection. The case of Raju, a 35-year-old farmer from Gadchiroli, exemplifies this shift. During a village health camp, Raju received a chest X-ray analyzed by Genki’s AI algorithm, leading to a TB diagnosis within minutes. This immediate result enabled prompt referral for treatment, curbing disease progression and reducing the risk of community transmission.

Empowering Frontline Health Workers in Tamil Nadu

In Tamil Nadu’s remote districts, Genki’s AI-driven platform has equipped community health workers—many without specialist radiology training—to conduct TB screenings independently. The tool’s user-friendly interface and rapid analysis have increased case detection rates and improved treatment initiation timelines. Health workers report that the ability to deliver immediate results reduces the stigma associated with TB, as patients no longer face prolonged uncertainty or repeated hospital visits.

Reducing Economic Burden and Enhancing Health Equity

The economic impact of delayed TB diagnosis is profound, particularly for daily wage earners and marginalized populations. By enabling early detection and treatment, Genki has helped minimize income loss and prevent catastrophic health expenditures. These outcomes align with the objectives of India’s National Strategic Plan for TB Elimination, which emphasizes the need for equitable access to diagnostics and care.

Expert Perspectives: Indian Voices on AI-Driven TB Control

Indian experts underscore the transformative yet nuanced role of AI in healthcare. Dr. Amit Kharat, co-founder of DeepTek, notes, “AI tools like Genki are not about replacing clinicians, but about extending the reach of quality diagnostics to the last mile.” Dr. Soumya Swaminathan, former Chief Scientist at the World Health Organization and a prominent Indian TB researcher, stresses the importance of integrating AI solutions within established national programs to ensure consistency with treatment protocols and robust data reporting.

Institutional research, led by the Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS), is actively evaluating AI’s role in infectious disease management.

Policy Integration and the Road Ahead

India’s policy landscape is increasingly supportive of AI-driven healthcare innovation. The National Tuberculosis Elimination Programme (NTEP) has begun integrating digital and AI tools to enhance screening and treatment adherence. The Digital Personal Data Protection (DPDP) Act, 2023, provides a legal foundation for safeguarding sensitive health data, a critical consideration for AI applications.

Looking forward, experts envision scaling Genki’s deployment nationwide, integrating AI diagnostics with electronic health records, and expanding capabilities to detect other respiratory diseases. Advances in explainable AI and federated learning are expected to enhance transparency and data privacy.

—

These impact stories and expert insights collectively highlight the transformative potential of AI-powered TB diagnostics in India. By bridging healthcare gaps, empowering frontline workers, and informing policy, AI tools like Genki are not only advancing clinical outcomes but also driving systemic change towards a more equitable and effective public health system.

Shaping the Future of TB Detection: Insights from India’s Leading AI and Health Experts

India stands at the forefront of integrating artificial intelligence into public health, particularly in the fight against tuberculosis (TB). As the country grapples with the world’s highest TB burden, Indian experts and institutions are driving a nuanced conversation around AI’s promise and pitfalls. Their perspectives highlight not only the technological advancements but also the ethical, operational, and policy dimensions critical to responsible AI adoption in healthcare.

AI as an Equalizer: Bridging Diagnostic Gaps in Resource-Limited Settings

Dr. Amit Kharat, co-founder of DeepTek and a pioneer in AI-powered radiology, emphasizes that AI tools like Genki are not designed to supplant clinicians, but to amplify their reach and accuracy. “In rural clinics where radiologists are scarce, Genki’s AI-driven chest X-ray analysis can flag probable TB cases in minutes, enabling faster triage and referral,” notes Dr. Kharat. This democratization of diagnostics is particularly impactful in India’s tier-2 and tier-3 cities, where healthcare infrastructure is often stretched thin.

A real-world example comes from Maharashtra, where Genki was piloted in district hospitals. The AI system reduced turnaround times for TB screening by over 50%. Such outcomes underscore AI’s potential to bridge longstanding urban-rural divides in healthcare access.

Integrating AI with National Health Programs: Ensuring Alignment and Accountability

Dr. Soumya Swaminathan, former Chief Scientist at the World Health Organization and a leading TB authority from India, stresses the importance of embedding AI solutions within established public health frameworks. “AI diagnostics must be validated rigorously and integrated with the National Tuberculosis Elimination Programme (NTEP) to ensure consistency with treatment protocols and data reporting systems,” she asserts.

This approach is reflected in the NTEP’s ongoing digital transformation, which includes piloting AI-based screening tools in collaboration with the Ministry of Health and Family Welfare. The integration of AI with Nikshay, India’s TB patient management system, is being explored to streamline case notifications and monitor treatment adherence.

Ethical Governance and Data Privacy: Building Public Trust in AI

Indian institutions such as ICMR, AIIMS, and the Centre for Artificial Intelligence and Robotics (CAIR) under the Defence Research and Development Organisation (DRDO) are at the forefront of developing ethical frameworks for AI in healthcare. Their research highlights the imperative for transparency, explainability, and robust data protection.

Dr. Priya Abraham, former director of the National Institute of Virology, cautions, “Without strong data governance and continuous monitoring, AI tools risk perpetuating biases or compromising patient confidentiality. Ethical guardrails must evolve alongside technological advances.”

Capacity Building and Indigenous Innovation: The Role of Indian Startups and Academia

India’s vibrant startup ecosystem and academic institutions are pivotal in localizing AI solutions for TB detection. DeepTek’s Genki, developed in Pune, exemplifies the Atmanirbhar Bharat (self-reliant India) initiative, offering a homegrown alternative to imported diagnostic platforms. Collaborative research between AIIMS, IITs, and private firms is accelerating the development of context-specific AI models, trained on diverse Indian datasets.

The IndiaAI Mission, launched by the government, provides funding, regulatory sandboxes, and mentorship to foster innovation in health AI. For instance, regulatory sandboxes allow startups to test AI algorithms in controlled environments, balancing innovation with patient safety. These initiatives not only spur technological progress but also build the capacity of healthcare professionals to effectively deploy and interpret AI tools.

Towards Inclusive and Sustainable AI Adoption

Experts consistently highlight the need for inclusivity in AI-driven healthcare. Dr. Anurag Agrawal, Dean at the Trivedi School of Biosciences, Ashoka University, points out, “For AI to truly transform TB care, it must be accessible to marginalized communities, account for linguistic diversity, and be integrated with grassroots health worker networks.”

Programs like Digital India and BharatNet are expanding digital infrastructure to rural areas, while gender-sensitive training modules ensure that female health workers can effectively use AI tools. Pilot projects in states like Uttar Pradesh demonstrate that community engagement and culturally tailored interfaces significantly improve adoption rates among underserved populations.

—

Indian experts and institutions are shaping a pragmatic yet ambitious roadmap for AI in TB detection—one that balances innovation with ethical stewardship, policy alignment, and social equity. Their collective vision is not only to harness AI’s transformative power but to do so in a manner that is transparent, accountable, and inclusive, setting a benchmark for global health innovation.

Harnessing Policy for AI-Driven Tuberculosis Detection in India

India stands at the forefront of leveraging artificial intelligence (AI) to combat public health challenges, particularly tuberculosis (TB). Strategic policy interventions, robust legal frameworks, and targeted government initiatives are shaping an ecosystem where AI solutions like DeepTek’s Genki can thrive. This section explores the nuanced policy landscape enabling AI-driven TB detection, drawing on real-world examples, regulatory milestones, and expert perspectives from India’s health and technology sectors.

National Initiatives Catalyzing AI in Public Health

The Indian government has launched a series of flagship programs to foster AI adoption in healthcare. The IndiaAI Mission, spearheaded by the Ministry of Electronics and Information Technology (MeitY), is a cornerstone policy that nurtures AI innovation through funding, research collaborations, and capacity building. For example, under this mission, AI-based tools such as Genki have been piloted in partnership with public hospitals to accelerate TB screening and diagnosis.

Another significant initiative is the National Tuberculosis Elimination Programme (NTEP), which integrates AI-driven digital platforms to enhance early TB detection and monitor treatment adherence. The NTEP’s collaboration with technology partners has resulted in the deployment of AI-powered chest X-ray analysis in high-burden districts, leading to improved case identification rates. These efforts are aligned with the government’s Atmanirbhar Bharat (self-reliant India) vision, encouraging indigenous solutions like Genki to address local health needs.

Legal and Regulatory Frameworks: Balancing Innovation and Privacy

The rapid integration of AI in healthcare necessitates robust data protection and ethical oversight. The Digital Personal Data Protection (DPDP) Act, 2023, marks a pivotal advancement by establishing comprehensive safeguards for sensitive health data. This legislation is particularly relevant for AI applications that rely on large-scale patient data for training and deployment.

MeitY’s proposed AI Diffusion Rules further aim to streamline the development and deployment of AI infrastructure, addressing concerns around security, transparency, and accountability. Regulatory sandboxes, as promoted by the Reserve Bank of India and MeitY, allow innovators to test AI solutions like Genki in controlled environments, ensuring that new technologies meet safety and efficacy standards before nationwide rollout.

According to Dr. Neeta Verma, former Director General of the National Informatics Centre, “India’s evolving regulatory landscape is designed to foster responsible AI innovation while safeguarding citizen rights—a balance critical for public trust in health technologies.”

Indigenous Innovation and Public-Private Partnerships

India’s policy emphasis on self-reliance has spurred indigenous AI development. DeepTek’s Genki exemplifies this approach, having been developed and validated within Indian clinical settings. The Atmanirbhar Bharat initiative provides incentives for domestic R&D, reducing reliance on imported technologies and tailoring solutions to local epidemiological patterns.

Public-private partnerships (PPPs) have proven instrumental in scaling AI solutions. For instance, collaborations between state health departments, AI startups, and academic institutions have enabled the deployment of Genki in Maharashtra and Tamil Nadu, resulting in faster TB case detection and improved patient outcomes.

Data Governance and Ethical Considerations

Effective AI deployment in healthcare hinges on strong data governance frameworks. The Ministry of Health and Family Welfare, in conjunction with MeitY, has issued guidelines on data anonymization, consent management, and interoperability standards for digital health records. These policies are integral to the National Digital Health Mission (NDHM), which envisions a unified digital health ecosystem.

Ethical concerns, such as algorithmic bias and equitable access, are addressed through inclusive policy design. The NDHM mandates that AI tools undergo rigorous validation across diverse demographic groups to minimize disparities in TB detection. Moreover, the integration of federated learning—a technique that enables AI models to learn from decentralized data without compromising privacy—is being explored in pilot projects across Karnataka and Uttar Pradesh.

Expert Perspectives: Indian Voices Shaping AI Policy

Indian experts and institutions play a pivotal role in shaping the policy discourse around AI in healthcare. Dr. Soumya Swaminathan, former Chief Scientist at the World Health Organization and a leading Indian TB researcher, emphasizes, “AI has the potential to bridge critical gaps in TB detection, but its success depends on transparent algorithms, community engagement, and robust regulatory oversight.”

The All India Institute of Medical Sciences (AIIMS) and the Indian Council of Medical Research (ICMR) are actively involved in evaluating AI tools for clinical efficacy and ethical compliance. Their research informs policy recommendations and standard-setting, ensuring that innovations like Genki are both effective and aligned with national health priorities.

—

India’s comprehensive policy ecosystem—spanning innovation missions, legal safeguards, indigenous development, and ethical oversight—provides a robust foundation for scaling AI-driven TB detection. By fostering collaboration between government, industry, and academia, and prioritizing data privacy and inclusivity, India is charting a path toward transformative public health outcomes.

Charting the Next Frontier: AI-Driven Tuberculosis Detection in India

As India stands at the cusp of a digital health revolution, the future of AI-powered tuberculosis (TB) detection promises to redefine public health outcomes. With the successful pilot of tools like Genki, the nation is poised to scale these innovations, integrate them into broader health systems, and harness emerging technologies for more precise, equitable, and proactive TB control. The convergence of policy, research, and technology signals a transformative era—one where AI not only augments diagnostics but also shapes the very fabric of healthcare delivery and disease prevention.

Nationwide Integration and Interoperability

The next logical step for AI-driven TB detection is seamless integration with India’s digital health infrastructure. The National Digital Health Mission (NDHM), launched by the Ministry of Health and Family Welfare, provides a robust framework for linking AI diagnostic tools with electronic health records (EHRs), ensuring real-time data flow and coordinated care across public and private sectors. States like Maharashtra and Tamil Nadu have already piloted AI-based chest X-ray analysis in district hospitals, demonstrating improved case detection rates and faster patient triage.

Beyond TB, these platforms can be expanded to screen for other respiratory illnesses, such as pneumonia and COVID-19, leveraging the same digital backbone.

Enhancing Explainability and Data Privacy

One of the key challenges in AI adoption is the ‘black box’ nature of many algorithms. Advances in explainable AI (XAI) are making it possible for clinicians and patients to understand the rationale behind diagnostic decisions, fostering greater trust and accountability. Indian research institutions like the Indian Institute of Science (IISc) and the Centre for Development of Advanced Computing (C-DAC) are at the forefront of developing interpretable AI models tailored for healthcare.

Simultaneously, federated learning—where AI models are trained across decentralized data sources without sharing sensitive patient data—offers a promising solution to privacy concerns. These innovations ensure that AI-driven diagnostics remain both transparent and secure, addressing ethical imperatives in public health.

Personalizing Care Through Genomics and Mobile Health

The future of TB management lies in personalized medicine, and AI is set to play a pivotal role. By integrating AI with genomics, clinicians can identify drug-resistant TB strains and tailor treatment regimens to individual patients. Combining these insights with mobile health (mHealth) platforms enables remote monitoring of treatment adherence—a critical factor in TB control.

For example, the Nikshay Poshan Yojana, a government program providing nutritional support to TB patients, is being enhanced with AI-driven adherence tracking via mobile apps. This not only improves patient outcomes but also generates valuable data for public health planning.

Predictive Analytics for Targeted Interventions

Looking ahead, AI-powered predictive analytics could revolutionize TB surveillance and intervention strategies. By analyzing epidemiological, environmental, and mobility data, AI models can identify emerging TB hotspots and forecast outbreaks with high precision. A notable success is the use of AI in Andhra Pradesh, where predictive models guided the deployment of mobile screening units to high-risk districts, resulting in a measurable uptick in early case detection and treatment initiation.

Expert Perspectives and Global Partnerships

Indian experts emphasize the importance of context-specific AI development and international collaboration. Partnerships with organizations like the Bill & Melinda Gates Foundation and the Global Fund have facilitated technology transfer, capacity building, and funding for AI-driven TB programs.

—

In sum, the future of AI-driven TB detection in India is anchored in nationwide integration, ethical innovation, personalized care, predictive analytics, and robust expert engagement. These advancements, underpinned by progressive policy and global partnerships, position India to not only achieve its TB elimination goals but also to set a benchmark for digital health innovation worldwide.

Bridging the Digital Divide: Making AI Tools Accessible for All

Equitable access to artificial intelligence (AI) in healthcare is not just a technological imperative but a social one—especially in a diverse nation like India. Tools such as Genki, designed for early tuberculosis (TB) detection, hold transformative promise. Yet, their impact hinges on reaching rural, gender-diverse, and marginalized communities who often face compounded barriers: limited digital literacy, language challenges, and infrastructural gaps. Addressing these issues requires a multi-layered approach rooted in inclusive policy, community engagement, and culturally sensitive design.

Targeting the Rural-Urban Digital Gap

India’s rural population, comprising nearly 65% of the country, remains at the frontline of the digital divide. The government’s flagship Digital India initiative and the BharatNet project have made significant strides in expanding broadband connectivity to over 180,000 gram panchayats (village councils) as of 2023. These infrastructural investments are foundational for deploying AI-powered health tools in remote areas. For example, pilot programs in states like Karnataka and Odisha have leveraged BharatNet’s connectivity to enable telemedicine consultations and AI-assisted TB screening in primary health centers.

However, connectivity alone is insufficient. Digital literacy remains a persistent challenge. The Pradhan Mantri Gramin Digital Saksharta Abhiyan (PMGDISHA) has trained over 40 million rural citizens in basic digital skills, with a focus on women and marginalized groups. Such programs are essential for ensuring that AI tools are not only available but also usable by those who need them most.

Language and Cultural Inclusion in AI Design

India’s linguistic diversity—over 22 official languages and hundreds of dialects—demands AI interfaces that go beyond English or Hindi. Research from the Indian Institute of Technology (IIT) Madras underscores the importance of multilingual AI systems for healthcare, noting that “language-agnostic interfaces significantly improve user engagement and diagnostic accuracy in rural populations.”

Genki and similar platforms are increasingly adopting Natural Language Processing (NLP) models trained on regional languages. For instance, the eSanjeevani telemedicine platform, supported by the Ministry of Health and Family Welfare, offers consultations in multiple Indian languages, setting a precedent for AI-based TB detection tools. Furthermore, culturally sensitive content—such as visual aids and voice prompts tailored to local customs—can bridge comprehension gaps, especially for women and older adults who may have limited formal education.

Gender-Sensitive Approaches and Community Health Workers

Gender disparities in digital access and healthcare utilization are well-documented in India. According to the National Family Health Survey (NFHS-5), women are 20% less likely than men to own a mobile phone. Addressing this gap requires targeted interventions. Training female Accredited Social Health Activists (ASHAs) and Auxiliary Nurse Midwives (ANMs) to use AI tools not only empowers them but also builds trust within communities where women may face cultural barriers to seeking care.

A case in point is the AI4WomenHealth initiative in Uttar Pradesh, where female health workers were equipped with AI-powered mobile applications for TB symptom screening. The project reported a 30% increase in early TB case identification among women, attributed to culturally sensitive outreach and the involvement of trusted community figures.

Ensuring Data Equity and Reducing Algorithmic Bias

AI systems are only as fair as the data they are trained on. Marginalized groups—such as tribal populations, transgender individuals, and persons with disabilities—are often underrepresented in health datasets, leading to biased outcomes. The Ministry of Social Justice and Empowerment’s digital inclusion policies emphasize the need for representative data collection and regular audits to identify and mitigate algorithmic bias.

For example, the National Digital Health Mission (NDHM) mandates that health data collection efforts include demographic markers relevant to marginalized communities. This approach is echoed by Dr. Sunita Nadhamuni, Head of Digital LifeCare at Dell Technologies India, who notes, “Inclusive data practices are critical for AI tools to deliver equitable health outcomes. Without them, we risk perpetuating existing disparities.”

Expert Perspectives: The Path Forward

Indian experts and institutions are at the forefront of advocating for accessible AI in healthcare. Dr. Anurag Agrawal, former Director of CSIR-Institute of Genomics and Integrative Biology, emphasizes, “Accessibility is not just about technology deployment—it’s about co-creating solutions with communities, respecting local knowledge, and ensuring sustained support.”

The National Health Authority’s guidelines on digital health innovation stress the importance of participatory design, where end-users—especially from marginalized backgrounds—are involved in testing and refining AI tools. This participatory approach is exemplified by the TB Champions program, where survivors and community volunteers provide feedback on AI-based screening platforms, ensuring they are intuitive and responsive to real-world needs.

—

In sum, making AI-powered healthcare tools like Genki accessible to all Indians is a complex but achievable goal. It demands coordinated action across infrastructure, education, design, data governance, and community engagement—guided by robust policy frameworks and informed by the lived experiences of those most at risk. Only then can the promise of AI-driven TB detection translate into tangible, equitable health outcomes for every segment of India’s population.

Unlocking Inclusive Engagement: Pathways for Participation in AI-Driven Healthcare

India’s rapid adoption of artificial intelligence (AI) in healthcare is not just a technological revolution—it is a movement that invites participation from citizens, institutions, and communities at every level. As the nation tackles persistent health challenges like tuberculosis (TB), the democratization of AI-driven solutions is crucial for ensuring equitable access, robust implementation, and sustainable impact. From grassroots initiatives to high-level policy collaborations, diverse stakeholders are shaping the future of health innovation in India.

Community-Driven Data Collection and Digital Literacy

Grassroots engagement forms the backbone of effective AI deployment in healthcare. Community health workers, such as Accredited Social Health Activists (ASHAs), are increasingly involved in data collection using AI-enabled mobile applications for TB screening and monitoring. For example, in Maharashtra, pilot projects have equipped ASHAs with AI-powered diagnostic tools, enabling real-time data entry and rapid case identification.

Digital literacy campaigns, often spearheaded by organizations like the Digital Empowerment Foundation, further empower citizens to interact with AI tools responsibly and effectively. These initiatives not only bridge the digital divide but also foster trust and transparency in AI-driven healthcare interventions.

Academic-Industry Collaborations and Research Networks

Academic institutions are pivotal in advancing AI research and translating innovations into practice. Indian Institutes of Technology (IITs) and All India Institutes of Medical Sciences (AIIMS) have established interdisciplinary research centers focused on AI in healthcare. For instance, IIT Bombay’s Centre for Machine Intelligence and Data Science (C-MInDS) collaborates with public hospitals to develop AI algorithms for TB detection from chest X-rays.

These partnerships are often supported by government grants and international collaborations. Such networks not only accelerate technological breakthroughs but also ensure that solutions are tailored to India’s unique epidemiological and socio-economic context.

Innovation Challenges and Startup Ecosystem Support

The Indian government actively fosters innovation through targeted challenges and funding schemes. The IndiaAI Mission, launched by MeitY, offers a suite of programs including the AI Innovation Challenge, which invites startups and entrepreneurs to develop scalable AI solutions for public health priorities like TB detection.

Startups such as Qure.ai and SigTuple have leveraged these opportunities to pilot and scale AI-based diagnostic tools across Indian states. The Biotechnology Industry Research Assistance Council (BIRAC) further supports early-stage ventures with grants and mentorship, catalyzing a vibrant ecosystem for health-tech innovation.

Policy Platforms and Stakeholder Engagement

Effective governance and stakeholder engagement are essential for responsible AI adoption. Platforms like the National AI Portal of India serve as centralized resources for policy updates, research publications, and opportunities for public consultation. The portal enables stakeholders—including policymakers, researchers, industry leaders, and civil society—to contribute to the evolving discourse on AI ethics, data privacy, and regulatory frameworks.

The National Health Authority (NHA) regularly solicits feedback from diverse groups during the formulation of digital health policies, ensuring that voices from marginalized communities are represented. This participatory approach is reflected in the draft National Strategy for Artificial Intelligence, which underscores the importance of multi-stakeholder collaboration for ethical and inclusive AI deployment.

Expert Perspectives: Indian Voices on Participation

Indian experts emphasize that meaningful participation is key to maximizing the benefits of AI in healthcare. Dr. Soumya Swaminathan, former Chief Scientist at the World Health Organization and a leading Indian TB researcher, has highlighted the need for “community ownership of digital health tools to ensure their relevance and sustainability.” Similarly, the Centre for Health Research and Innovation (CHRI) in Delhi advocates for co-designing AI interventions with frontline health workers and patients, citing improved adoption and outcomes.

—

By leveraging these diverse participation opportunities, India is building a resilient and inclusive ecosystem for AI-driven healthcare. The convergence of community action, academic rigor, entrepreneurial energy, and policy foresight is setting new benchmarks for global health innovation—ensuring that the promise of AI reaches every corner of the country.

DeepTek’s AI-Powered Tool ‘Genki’ for Rapid TB Detection – https://thebetterindia.com/331526/pune-startup-innovates-ai-based-technology-screen-tuberculosis-within-seconds-innovation-in-healthcare/
Implementing a Chest X-ray Artificial Intelligence Tool to Enhance Tuberculosis Screening in India: Lessons Learned – https://journals.plos.org/digitalhealth/article?id=10.1371%2Fjournal.pdig.0000404
Artificial Intelligence: The New Weapon to END TB – Lung India – https://journals.lww.com/lungindia/fulltext/2024/11000/artificial_intelligencethe_new_weapon_to_end_tb.17.aspx
Understanding Providers’ Attitude Toward AI in India’s Informal Healthcare Sector for TB Diagnosis – https://formative.jmir.org/2025/1/e54156
A Systematic Review and Meta-Analysis of the Diagnostic Accuracy of AI for Tuberculosis Screening – https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5242653